ArticleImmunity, inflammation and disease2026
Mitochondrial Abnormalities of T Lymphocytes in Patients With Maintenance Hemodialysis.
Article in Immunity, inflammation and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Alterations in T lymphocyte subsets and mitochondrial-related parameters in patients with chronic kidney disease.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo investigate the characteristics of T lymphocyte subsets and mitochondrial function in hemodialysis patients and to explore the effect of hemodialysis on these parameters.
methodsPatients with end-stage renal disease (ESRD) from July 2023 to June 2024, who underwent mitochondrial function detection of T lymphocyte subsets, were included in this retrospective study. Patients were categorized into a hemodialysis group and a pre-dialysis group based on whether they received hemodialysis. The hemodialysis group was further divided into those with dialysis duration ≤ 12 months and those with > 12 months. Peripheral blood from ESRD patients was analyzed by flow cytometry to obtain data on T lymphocyte subsets, mitochondrial mass (MM), and low mitochondrial membrane potential (MMP-Low). Differences in T lymphocyte subsets mitochondrial parameters among distinct groups were analyzed, and the association between hemodialysis and the aforementioned mitochondrial parameters was investigated using multiple linear regression analysis.
resultsA total of 250 patients were enrolled (153 hemodialysis and 97 pre-dialysis). Compared with the pre-dialysis group, the hemodialysis group had significantly lower white blood cell count (5.62 ± 1.63 vs. 6.49 ± 1.93 × 10
conclusionT lymphocyte MM and MMP-Low% differ significantly between hemodialysis and pre-dialysis ESRD patients, and hemodialysis patients exhibit more pronounced T lymphocyte mitochondrial dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.